doi: 10.3389/fphar.2014.00181 Received 31 May 2014 Accepted 16 July 2014 Published 11 August 2014 Volume 5 - 2014 Edited by Alfonso Pompella, Universit di Pisa, Italy Reviewed by Marc Diederich, Laboratoire de Biologie Molculaire et Cellulaire du Cancer, Hpital Kirchberg, Luxembourg
Aphexda was approved in combination with filgrastim (G-CSF), a granulocyte colony-stimulating factor that stimulates the growth of neutrophils
Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab
Other symptoms include pelvic pain, weight gain or trouble losing weight, acne, and thick skin with dark patches
Think of it like this: peptides are large, carefully folded molecules